Position in GILD
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$304,353
-$13,549 QoQ
Shares Held
2,409
+5.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,637
of 2,266 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Apella Capital, LLC holds $29,919,337 across 10 Drug Manufacturers - General names. GILD ranks #9 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
42,479 | $10,788,391 | |
| 2 | ABBV |
AbbVie Inc.
|
20,565 | $5,174,976 | |
| 3 | LLY |
ELI LILLY & Co
|
4,276 | $5,128,763 | |
| 4 | MRK |
Merck & Co., Inc.
|
37,663 | $4,839,695 | |
| 5 | PFE |
Pfizer Inc
|
46,600 | $1,122,128 | |
| 6 | AMGN |
Amgen Inc
|
2,984 | $1,080,566 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
12,792 | $737,075 | |
| 8 | NVS |
Novartis AG
|
2,960 | $463,891 |
All Filings in GILD
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $304,353 | 2,409 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $317,902 | 2,281 | Shares | Sole | 2026-04-20 | |
| 2021-06-30 | $202,448 | 2,940 | Shares | Sole | 2022-01-18 | |
| 2021-03-31 | $239,906 | 3,712 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $282,327 | 4,846 | Shares | Sole | 2021-02-18 | |
| 2020-09-30 | $306,218 | 4,846 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $372,774 | 4,845 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $341,952 | 4,574 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||